181 related articles for article (PubMed ID: 36625284)
1. Human DNA ligases I and III have stand-alone end-joining capability, but differ in ligation efficiency and specificity.
McNally JR; Ames AM; Admiraal SJ; O'Brien PJ
Nucleic Acids Res; 2023 Jan; 51(2):796-805. PubMed ID: 36625284
[TBL] [Abstract][Full Text] [Related]
2. Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining.
Lu G; Duan J; Shu S; Wang X; Gao L; Guo J; Zhang Y
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1256-60. PubMed ID: 26787905
[TBL] [Abstract][Full Text] [Related]
3. Alternative Okazaki Fragment Ligation Pathway by DNA Ligase III.
Arakawa H; Iliakis G
Genes (Basel); 2015 Jun; 6(2):385-98. PubMed ID: 26110316
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analyses of single-stranded break repair by human DNA ligase III isoforms reveal biochemical differences from DNA ligase I.
McNally JR; O'Brien PJ
J Biol Chem; 2017 Sep; 292(38):15870-15879. PubMed ID: 28751376
[TBL] [Abstract][Full Text] [Related]
5. Ku70 suppresses alternative end joining in G1-arrested progenitor B cells.
Liang Z; Kumar V; Le Bouteiller M; Zurita J; Kenrick J; Lin SG; Lou J; Hu J; Ye AY; Boboila C; Alt FW; Frock RL
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006647
[TBL] [Abstract][Full Text] [Related]
6. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
Soni A; Siemann M; Pantelias GE; Iliakis G
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
[TBL] [Abstract][Full Text] [Related]
7. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
[TBL] [Abstract][Full Text] [Related]
8. Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.
Ali R; Alabdullah M; Algethami M; Alblihy A; Miligy I; Shoqafi A; Mesquita KA; Abdel-Fatah T; Chan SY; Chiang PW; Mongan NP; Rakha EA; Tomkinson AE; Madhusudan S
Theranostics; 2021; 11(17):8350-8361. PubMed ID: 34373746
[No Abstract] [Full Text] [Related]
9. Catalytically inactive DNA ligase IV promotes DNA repair in living cells.
Goff NJ; Brenière M; Buehl CJ; de Melo AJ; Huskova H; Ochi T; Blundell TL; Mao W; Yu K; Modesti M; Meek K
Nucleic Acids Res; 2022 Oct; 50(19):11058-11071. PubMed ID: 36263813
[TBL] [Abstract][Full Text] [Related]
10. DNA ligases I and III cooperate in alternative non-homologous end-joining in vertebrates.
Paul K; Wang M; Mladenov E; Bencsik-Theilen A; Bednar T; Wu W; Arakawa H; Iliakis G
PLoS One; 2013; 8(3):e59505. PubMed ID: 23555685
[TBL] [Abstract][Full Text] [Related]
11. Redundant function of DNA ligase 1 and 3 in alternative end-joining during immunoglobulin class switch recombination.
Masani S; Han L; Meek K; Yu K
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1261-6. PubMed ID: 26787901
[TBL] [Abstract][Full Text] [Related]
12. Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1).
Boboila C; Oksenych V; Gostissa M; Wang JH; Zha S; Zhang Y; Chai H; Lee CS; Jankovic M; Saez LM; Nussenzweig MC; McKinnon PJ; Alt FW; Schwer B
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2473-8. PubMed ID: 22308491
[TBL] [Abstract][Full Text] [Related]
13. Ligase 3-mediated end-joining maintains genome stability of human embryonic stem cells.
Kohutova A; Raška J; Kruta M; Seneklova M; Barta T; Fojtik P; Jurakova T; Walter CA; Hampl A; Dvorak P; Rotrekl V
FASEB J; 2019 Jun; 33(6):6778-6788. PubMed ID: 30807703
[TBL] [Abstract][Full Text] [Related]
14. Human DNA ligases in replication and repair.
Sallmyr A; Rashid I; Bhandari SK; Naila T; Tomkinson AE
DNA Repair (Amst); 2020 Sep; 93():102908. PubMed ID: 33087274
[TBL] [Abstract][Full Text] [Related]
15. Role for Artemis nuclease in the repair of radiation-induced DNA double strand breaks by alternative end joining.
Moscariello M; Wieloch R; Kurosawa A; Li F; Adachi N; Mladenov E; Iliakis G
DNA Repair (Amst); 2015 Jul; 31():29-40. PubMed ID: 25973742
[TBL] [Abstract][Full Text] [Related]
16. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4.
Boboila C; Yan C; Wesemann DR; Jankovic M; Wang JH; Manis J; Nussenzweig A; Nussenzweig M; Alt FW
J Exp Med; 2010 Feb; 207(2):417-27. PubMed ID: 20142431
[TBL] [Abstract][Full Text] [Related]
17. LIG1 syndrome mutations remodel a cooperative network of ligand binding interactions to compromise ligation efficiency.
Jurkiw TJ; Tumbale PP; Schellenberg MJ; Cunningham-Rundles C; Williams RS; O'Brien PJ
Nucleic Acids Res; 2021 Feb; 49(3):1619-1630. PubMed ID: 33444456
[TBL] [Abstract][Full Text] [Related]
18. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
[TBL] [Abstract][Full Text] [Related]
19. HPF1-dependent PARP activation promotes LIG3-XRCC1-mediated backup pathway of Okazaki fragment ligation.
Kumamoto S; Nishiyama A; Chiba Y; Miyashita R; Konishi C; Azuma Y; Nakanishi M
Nucleic Acids Res; 2021 May; 49(9):5003-5016. PubMed ID: 33872376
[TBL] [Abstract][Full Text] [Related]
20. Structures of LIG1 provide a mechanistic basis for understanding a lack of sugar discrimination against a ribonucleotide at the 3'-end of nick DNA.
Balu KE; Gulkis M; Almohdar D; Çağlayan M
J Biol Chem; 2024 May; 300(5):107216. PubMed ID: 38522520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
